Latest News


JavaScript findLinksAndSetTargets()
(to open ext. links in new window)

Story Highlights

The U.S. is facing a crisis due to associated opioid use and overdose deaths.

TACC announced its role as a key collaborator in a first-of-its-kind NIH grant to investigate and understand the biological characteristics underlying the transition from acute to chronic pain and the subsequent dependence or addiction to opioids.

The NIH Acute to Chronic Pain Signatures (A2CPS) program will be the most comprehensive study to date to investigate the connections of peripheral biology, brain, psychological, and bio-behavioral risk factors.

TACC will receive $2.3 million to develop a meta-portal — an intuitive, analysis platform that will provide access to powerful tools and datasets, including private and data.

Goals: To impact future clinical trials, to be used as a springboard for developing new drugs, and to help to end long-term addiction.


Faith Singer

Communications Manager | 512-232-5771

Aaron Dubrow

Science And Technology Writer

Jorge Salazar

Technical Writer/Editor | 512-475-9411